SIRT1 ameliorates oxidative stress induced neural cell death and is down-regulated in Parkinson's disease

• Published in: BMC neuroscience Vol. 18; no. 1; pp. 46 - 13
• Main Authors: Singh, Preeti, Hanson, Peter S, Morris, Christopher M
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 02.06.2017; BioMed Central; BMC
• Subjects: Aged; Aged, 80 and over; Aging; Alpha-synuclein; Antioxidants; Apoptosis; Biosynthesis; Cell death; Cell Death - physiology; Cell Line; Cell survival; Dementia; Dementia disorders; Down-Regulation; Female; Gene expression; Humans; Lewy bodies; Life span; Longevity; Lysine; Male; NAD; NAD (Coenzyme); Neurodegeneration; Neurodegenerative diseases; Neurons; Neurons - metabolism; Overexpression; Oxidative stress; Oxidative Stress - physiology; Parkinson Disease - metabolism; Parkinson's disease; Plasmids; Proteins; SIRT1; SIRT1 protein; Sirtuin 1 - metabolism; Sirtuins; Survival; Synuclein; Transcription factors; United Kingdom > UK; Oxidative stress; Cell survival; SIRT1; Alpha-synuclein; Parkinson’s disease
• ISSN: 1471-2202; 1471-2202
• DOI: 10.1186/s12868-017-0364-1

Sirtuins (SIRTs) are NAD dependent lysine deacetylases which are conserved from bacteria to humans and have been associated with longevity and lifespan extension. SIRT1, the best studied mammalian SIRT is involved in many physiological and pathological processes and changes in SIRT1 have been implicated in neurodegenerative disorders, with SIRT1 having a suggested protective role in Parkinson's disease. In this study, we determined the effect of SIRT1 on cell survival and α-synuclein aggregate formation in SH-SY5Y cells following oxidative stress. Over-expression of SIRT1 protected SH-SY5Y cells from toxin induced cell death and the protection conferred by SIRT1 was partially independent of its deacetylase activity, which was associated with the repression of NF-кB and cPARP expression. SIRT1 reduced the formation of α-synuclein aggregates but showed minimal co-localisation with α-synuclein. In post-mortem brain tissue obtained from patients with Parkinson's disease, Parkinson's disease with dementia, dementia with Lewy bodies and Alzheimer's disease, the activity of SIRT1 was observed to be down-regulated. These findings suggests a negative effect of oxidative stress in neurodegenerative disorders and possibly explain the reduced activity of SIRT1 in neurodegenerative disorders. Our study shows that SIRT1 is a pro-survival protein that is downregulated under cellular stress.